Learn about our mission
Rescue is what we do
Theripion’s novel research has applications rescuing patients from dozens of the worlds most debilitating diseases.
We focus on transformative therapies that, in collaboration with leading pharmaceutical companies, can efficiently deliver real solutions to patients with unmet medical needs
Novel research
Theripion’s research has led to the discovery of several novel and useful applications of existing proteins and enzymes.
Ther4, TR-22, TR-43, and our Paraoxonase Fusion Protein Platform provide a first-in-class platform for combination therapies.
Learn about the science behind these patents
Engage with us
Business strategy and the future
Theripion is a privately held, Seattle-based biotechnology company. We are looking to propel our innovations into the clinical trials phase.
We have secured patent protection on our work, and are interested in partnering with investors and bio-pharmaceutical companies.
Who we are
Theripion founders and partners include industry proven researchers and scientists in the fields of immunology, Rheumatology, molecular biology, and Endocrinology.
We are looking to combine our expertise and experience with partnering companies and funding to pursue an Investigational New Drug Application from the FDA.
Meet the team behind Theripion